Spire Wealth Management Buys 8,271 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Spire Wealth Management grew its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 4,094.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,473 shares of the biotechnology company's stock after acquiring an additional 8,271 shares during the quarter. Spire Wealth Management's holdings in Axon Enterprise were worth $5,036,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. New Wave Wealth Advisors LLC purchased a new stake in shares of Axon Enterprise in the fourth quarter worth approximately $40,000. Quent Capital LLC raised its position in Axon Enterprise by 1,875.0% in the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company's stock valued at $32,000 after buying an additional 75 shares during the last quarter. Prestige Wealth Management Group LLC lifted its stake in Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company's stock valued at $33,000 after acquiring an additional 44 shares in the last quarter. Versant Capital Management Inc boosted its holdings in Axon Enterprise by 4,750.0% during the 4th quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company's stock worth $58,000 after acquiring an additional 95 shares during the last quarter. Finally, Berbice Capital Management LLC bought a new stake in shares of Axon Enterprise in the 4th quarter worth $59,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on AXON. JMP Securities boosted their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a "market outperform" rating in a report on Thursday, October 31st. Morgan Stanley upgraded Axon Enterprise from an "equal weight" rating to an "overweight" rating and boosted their target price for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Needham & Company LLC increased their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a "buy" rating in a research report on Friday, November 8th. Robert W. Baird boosted their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a research report on Friday, December 6th. Finally, The Goldman Sachs Group raised their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a research report on Monday, January 27th. One analyst has rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, Axon Enterprise currently has a consensus rating of "Moderate Buy" and a consensus target price of $524.85.

Insider Buying and Selling at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares of the company's stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Joshua Isner sold 20,000 shares of the stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the completion of the sale, the president now owns 208,166 shares in the company, valued at $126,179,820.90. This represents a 8.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 50,545 shares of company stock valued at $30,721,337 in the last 90 days. 5.70% of the stock is currently owned by company insiders.

Axon Enterprise Stock Performance

Shares of AXON stock traded up $5.93 during trading on Monday, reaching $658.11. 1,000,481 shares of the company's stock traded hands, compared to its average volume of 588,501. The firm's 50-day moving average is $619.63 and its 200 day moving average is $483.68. The company has a market capitalization of $50.18 billion, a P/E ratio of 170.05, a PEG ratio of 6.54 and a beta of 1.05. Axon Enterprise, Inc. has a 1 year low of $252.20 and a 1 year high of $698.67. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.